About this digest
A hand-kept record of the GLOW peptide literature.
Medicine Glow is an independent editorial project that reads the published research on GLOW's three constituent peptides — and marks the gap where the blend's own evidence should be.
What Medicine Glow is
Medicine Glow is an independent editorial project that publishes summaries of the peer-reviewed research literature on the GLOW peptide blend and its constituents — GHK-Cu, BPC-157 and TB-500. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The word "Medicine" in our name is editorial framing — a position this publisher occupies relative to the literature, reading it the way a careful pharmacology desk would. It is not a claim that this site offers treatment, consultation, prescriptions, or any medical service. We hold no pharmacy, no dispensary, and no clinical staff. What we keep is a reading room and a citation list.
GLOW peptide reviews vs a literature digest: how to read this site
GLOW peptide reviews online range from product pages to forum anecdotes; this site is neither. It is a literature digest, which means every claim is tied to a named study and the gaps are printed in plain sight rather than smoothed over. When the evidence is topical, we say topical. When a human dataset has two subjects, we say two. When the GLOW blend itself has no trial — which is the case for every efficacy claim about the combination — we say so on the page where the claim appears.
That editorial discipline is the whole point. The constituent peptides have a genuinely interesting record: GHK-Cu's collagen and matrix biology [1][2], BPC-157's tendon-healing and VEGFR2 angiogenesis [3][4], thymosin beta-4's wound-healing and the 40-volunteer Phase 1 safety study [5][6]. The blend that combines them is, as of today, an untested composite. A good digest lets both of those be true at once — and points you to the GLOW legal status and FDA 503A category for the regulatory reality alongside the science.
What we do not do
We do not recommend doses, protocols, or routes of administration for any human. We do not name vendors, clinics, pharmacies, or telehealth providers. We do not present community injection protocols as validated dosing. We do not assert that any pending regulatory change has occurred. And we describe research findings only — in "studied at X in this species or model" framing — never as guidance for use.
If you want the underlying papers, the studies cited on this site are listed in full with PubMed and DOI links. If you want a plain-language route through the science, start with how the GLOW blend works.